RxDoctor Payments Data

Brooke Harmon

Richmond, VANPI 1700652492

Payments from drug & device makers

$2,807in general payments, 2019–2025

Across 129 payments — averaging $21.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$774
  • AbbVie$417
  • UCB, Inc.$368
  • Novartis$224
  • LEO Pharma Inc.$212
  • Lilly USA, LLC$190
  • plus $622 from 12 others

What the payments were for

  • Food & beverage$2,54591%
  • Education$2629%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate44$1,593
Fluorouracil21$1,564
Ketoconazole61$1,062
Fluocinonide23$697
Triamcinolone Acetonide71$639
Metronidazole12$420
Hydrocortisone21$99

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →